Skip to main content
. 2020 Feb 13;15:33. doi: 10.1186/s13014-020-1479-6

Table 7.

Details on patients who developed Symptomatic Radiation Pneumonitis and the Outlier with extreme DVH values who did not develop radiation pneumonitis

Age Dose scheme Synchronously treated lesions? Largest tumor size Date from SBRT to RP Date from SBRT to death Prior RT to lung? (months) MLD V20
Developed Symptomatic Radiation Pneumonitis
 Patient 1 75 60/8 No 3.3 cm 3.3 mo Alive SBRT (20 mo) 9.6 Gy 10.3%
 Patient 2 50 50/5 Yes 1.6 cm 2.3 mo Alive CCRT (9 mo) 7.3 Gy 12.5%
 Patient 3 80 50/5 Yes 3.6 cm 7.4 mo 8 mo No 8.2 Gy 9.9%
 Patient 4 68 50/5 No 4.0 cm 0.8 mo 2.7 mo No 7.4 Gy 6.0%
 Patient 5 60 50/5 No Liver 5.6 mo Alive No 6.7 Gy 9.7%
 Patient 6 80 60/6 No 2.8 cm 5 mo Alive No 4.7 Gy 8.1%
 Patient 7 71 50/5 No 1.7 cm 1.2 mo Alive CCRT (3 mo) 4.2 Gy 4.7%
 Patient 8 74 50/5 No 3.5 cm 5.3 mo Alive No 4.1 Gy 5.5%
Outlier who did not develop Symptomatic Radiation Pneumonitis
 Outlier 1 10 50/5 Yes 1.9 cm n/a Alive No 11.0 Gy 18.4%

Only one patient appeared to have experienced death which may have been attributable to symptomatic RP (Patient #4)

This table corresponds to Appendix: Individual Patient Data in the Figures file